Coronavirus Pipeline: GSK And Clover Add To Collaborations
Pipeline Review – Update On Companies Joining Research
Executive Summary
Companies continue to throw their hats into the ring against the virus, with strategies ranging from ‘off the shelf’ molecules to novel vaccine and anti-viral therapies
You may also be interested in...
Coronavirus Update: With New Data, Don’t Count J&J Out Yet
J&J announced strong data for its single-shot vaccine, with even stronger booster shot data to boot. Also Gilead posted strong results for outpatient use of Veklury, but it faces stiff competition, while Clover announced new data and Pfizer/BioNTech sold another 500 million vaccine doses for donation.
AZ and GSK Dip Into Diagnostics To Support COVID-19 UK Tests
The pharma giants are joining forces to help the UK reach its ambitious target of testing 100,000 people a day for coronavirus by the end of April.
Coronavirus Update: UK Calls For COVID-19 Patients To Join Trials
GSK creates another partnership centered on its vaccine adjuvant technology, this time with China's Xiamen Innovax.